Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 2022
Integrated DNA and RNA Sequencing Reveals Drivers of Endocrine Resistance in Estrogen Receptor-Positive Breast CancerYouli Xia, Xiaping He, Lorna Renshaw, et al.Advances in Therapy|March 13, 2019
Accurate Estrogen Receptor Quantification in Patients with Negative and Low-Positive Estrogen-Receptor-Expressing Breast Tumors: Sub-Analyses of Data from Two Clinical StudiesJ Michael Dixon, David A Cameron, Laura M Arthur, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Cyclooxygenase-2 inhibition does not improve the reduction in ductal carcinoma in situ proliferation with aromatase inhibitor therapy: results of the ERISAC randomized placebo-controlled trialNigel J Bundred, Angela Cramer, Julie Morris, et al.Pharmacogenetics and Genomics|September 22, 2007
Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozoleWilliam R Miller, Alexey A Larionov, Lorna Renshaw, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 7, 2006
Estrogen-independent proliferation is present in estrogen-receptor HER2-positive primary breast cancer after neoadjuvant letrozoleMatthew J Ellis, Yu Tao, Oliver Young, et al.Breast Cancer Research : BCR|April 19, 2015
Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancerElena López-Knowles, Paul M Wilkerson, Ricardo Ribas, et al.Oncotarget|August 11, 2015
Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer modelsCarol Ward, James Meehan, Peter Mullen, et al.BMC Bioinformatics|January 30, 2020
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: comparison of gene expression profiling approachesArran K Turnbull, Cigdem Selli, Carlos Martinez-Perez, et al.Proceedings of the National Academy of Sciences of the United States of America|August 12, 2009
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating featuresChad J Creighton, Xiaoxian Li, Melissa Landis, et al.Pageof 3